What have we learned about TP53-mutated acute myeloid leukemia?
Abstract TP53 is a tumor suppressor gene frequently mutated in human cancers and is generally associated with poor outcomes. TP53 mutations are found in approximately 5% to 10% of patients with de novo acute myeloid leukemia (AML), more frequently observed in elderly patients and those with therapy-...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2024-11-01
|
| Sarja: | Blood Cancer Journal |
| Linkit: | https://doi.org/10.1038/s41408-024-01186-5 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|